Mabqi uses its proprietary phage display technology to deliver to our partners antibodies with the desired characteristics, fit for continued drug development.
Each asset is assigned to a dedicated team, focused on a single target at a time, to configure project plans and antibody selection schemes adjusted to the antigen and objectives.
Mabqi works in tandem with its corresponding academic platform “GenAc” and Inserm lab for very active research and R&D collaboration to continuously improve and innovate in our methods and tools.
Our team consolidates management excellence and best in class scientific expertise that can be traced back to the founding of fully human antibody phage display libraries.
Bernard Pau PhD
Sylvain Yon PhD
Gautier Robin PhD
Medical Advisory Board
Created in 2021, Mabqi Medical Advisory Board is composed of 5 International experts who provide medical and economic insight to identify and validate promising therapeutic targets with high clinical need.